Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw
Authors:
- Mitsunobu OtsuruMOMitsunobu Otsuru
- Sakiko SoutomeSSSakiko Soutome
- Keisuke OmoriKOKeisuke Omori
- Koki SuyamaKSKoki Suyama
- Kota MorishitaKMKota Morishita
- Saki HayashidaSHSaki Hayashida
- Maho MurataMMMaho Murata
- Yukinori TakagiYTYukinori Takagi
- Miho SasakiMSMiho Sasaki
- Misa SumiMSMisa Sumi
- Yuka KojimaYKYuka Kojima
- Shunsuke SawadaSSShunsuke Sawada
Open Access
- 12 April 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (8) , 4624
Abstract
It is controversial as to whether the withdrawal of antiresorptive (AR) agents is necessary while treating medication-related osteonecrosis of the jaw (MRONJ). In this study, we investigated whether a drug holiday promoted sequestrum separation and improved the surgical outcomes of MRONJ patients with malignant tumors, who were undergoing high-dose AR therapy. In total, we included 103 MRONJ patients with malignant tumors as their primary disease who underwent surgery at Nagasaki University Hospital or Kansai Medical University Hospital from January 2009 to December 2020. We recorded the patients’ age, sex, primary disease, MRONJ stage, type and administration period of the AR agent, presence of diabetes, corticosteroid use, drug holiday period, white blood cell count, serum albumin, serum creatinine, outcomes, and computed tomography findings. The relationships between a drug holiday and sequestrum separation, and between a drug holiday and outcome, were analyzed. Drug holidays of 60, 90, and 120 days were not significant factors of sequestrum separation and did not influence patients’ surgical outcomes as per the univariate and multivariate analyses. MRONJ patients with cancer as their primary disease should be operated upon immediately and without drug holidays if their general condition permits surgery.Keywords
This publication has 18 references indexed in Scilit:
- Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the JawJournal of Bone and Mineral Metabolism, 2016
- Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic reviewInternational Journal of Oral and Maxillofacial Surgery, 2015
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International ConsensusJournal of Bone and Mineral Research, 2014
- A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)Oral Oncology, 2014
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 UpdateJournal of Oral and Maxillofacial Surgery, 2014
- Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays.2013
- Denosumab: mechanism of action and clinical outcomesInternational Journal Of Clinical Practice, 2012
- Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosisThe Journal of the American Dental Association, 2011
- Denosumab and bisphosphonates: Different mechanisms of action and effectsBone, 2011
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 UpdateJournal of Oral and Maxillofacial Surgery, 2009